162 related articles for article (PubMed ID: 30603905)
1. FDG PET/CT to predict the curability of endoscopic resection for early gastric cancer.
Chung HW; Kim JH; Sung IK; Lee SY; Park HS; Shim CS; Bang HY; So Y; Lee EJ
J Cancer Res Clin Oncol; 2019 Mar; 145(3):759-764. PubMed ID: 30603905
[TBL] [Abstract][Full Text] [Related]
2. Prediction model for non-curative resection of endoscopic submucosal dissection in patients with early gastric cancer.
Kim EH; Park JC; Song IJ; Kim YJ; Joh DH; Hahn KY; Lee YK; Kim HY; Chung H; Shin SK; Lee SK; Lee YC
Gastrointest Endosc; 2017 May; 85(5):976-983. PubMed ID: 27756614
[TBL] [Abstract][Full Text] [Related]
3. Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT.
Kawanaka Y; Kitajima K; Fukushima K; Mouri M; Doi H; Oshima T; Niwa H; Kaibe N; Sasako M; Tomita T; Miwa H; Hirota S
Eur J Radiol; 2016 May; 85(5):989-95. PubMed ID: 27130061
[TBL] [Abstract][Full Text] [Related]
4. Early Gastric Cancers: Is CT Surveillance Necessary after Curative Endoscopic Submucosal Resection for Cancers That Meet the Expanded Criteria?
Choi KS; Kim SH; Kim SG; Han JK
Radiology; 2016 Nov; 281(2):444-453. PubMed ID: 27243549
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy comparison between surgical resection and endoscopic submucosal dissection of early gastric cancer in a domestic single center].
Rong L; Cai Y; Nian W; Wang X; Liang J; He Y; Zhang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):190-195. PubMed ID: 29492919
[TBL] [Abstract][Full Text] [Related]
6. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
Yun M; Lim JS; Noh SH; Hyung WJ; Cheong JH; Bong JK; Cho A; Lee JD
J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706
[TBL] [Abstract][Full Text] [Related]
7. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ
Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of FDG PET/CT for surveillance in asymptomatic gastric cancer patients after curative surgical resection.
Lee JW; Lee SM; Son MW; Lee MS
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):881-888. PubMed ID: 26611426
[TBL] [Abstract][Full Text] [Related]
9. Clinical implication of FDG uptake of bone marrow on PET/CT in gastric cancer patients with surgical resection.
Lee JW; Lee MS; Chung IK; Son MW; Cho YS; Lee SM
World J Gastroenterol; 2017 Apr; 23(13):2385-2395. PubMed ID: 28428718
[TBL] [Abstract][Full Text] [Related]
10.
Nakajima M; Muroi H; Yokoyama H; Kikuchi M; Yamaguchi S; Sasaki K; Kato H
Cancer Med; 2018 Aug; 7(8):3604-3610. PubMed ID: 29953743
[No Abstract] [Full Text] [Related]
11. A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
Smyth E; Schöder H; Strong VE; Capanu M; Kelsen DP; Coit DG; Shah MA
Cancer; 2012 Nov; 118(22):5481-8. PubMed ID: 22549558
[TBL] [Abstract][Full Text] [Related]
12. Relationship Between 18F-FDG PET/CT Findings and HER2 Expression in Gastric Cancer.
Chen R; Zhou X; Liu J; Huang G
J Nucl Med; 2016 Jul; 57(7):1040-4. PubMed ID: 26966162
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic parameters associated with the FDG-avidity in staging of early gastric cancer using 18F-FDG PET.
Yoon JK; Byun C; Jo KS; Hur H; Lee KM; Lim SK; Lee D; Lee SJ; An YS; Han SU
Medicine (Baltimore); 2019 Aug; 98(31):e16690. PubMed ID: 31374056
[TBL] [Abstract][Full Text] [Related]
14. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma.
Li XF; Fu Q; Dong YW; Liu JJ; Song XY; Dai D; Zuo C; Xu WG
World J Gastroenterol; 2016 Sep; 22(34):7787-96. PubMed ID: 27678362
[TBL] [Abstract][Full Text] [Related]
15. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.
Ciftci E; Turgut B; Cakmakcilar A; Erturk SA
Nucl Med Commun; 2017 Sep; 38(9):788-794. PubMed ID: 28692494
[TBL] [Abstract][Full Text] [Related]
17. Temporal evolution of multidetector CT findings after endoscopic submucosal dissection in patients with early gastric cancer: correlation with endoscopy.
Yeo DM; Chung DJ; Cheung DY; Lee JM
Eur J Radiol; 2014 Jun; 83(6):880-885. PubMed ID: 24673979
[TBL] [Abstract][Full Text] [Related]
18. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.
Chen J; Cheong JH; Yun MJ; Kim J; Lim JS; Hyung WJ; Noh SH
Cancer; 2005 Jun; 103(11):2383-90. PubMed ID: 15856477
[TBL] [Abstract][Full Text] [Related]
19. Interim Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict Pathologic Response to Preoperative Chemoradiotherapy and Prognosis in Patients With Locally Advanced Rectal Cancer.
Koo PJ; Kim SJ; Chang S; Kwak JJ
Clin Colorectal Cancer; 2016 Dec; 15(4):e213-e219. PubMed ID: 27316919
[TBL] [Abstract][Full Text] [Related]
20. Fluorine-18-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer after surgical resection: a systematic review and meta-analysis.
Li P; Liu Q; Wang C; Wang T; Liu J; Huang G; Song S
Ann Nucl Med; 2016 Apr; 30(3):179-87. PubMed ID: 26830546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]